2Suppliers
2Customers
3Debt Items
0Related Chains

Castle Biosciences, Inc. Suppliers

TickerNameConfidenceEvidence
SCIBASE SCIBASE 90% SciBase is entitled to royalties on our product sales, a mark-up on product sales to us, and a milestone payment upon achieving specified sales thresholds.
NORIDIAN-HEALTHCARE-SOLUTIONS-LLC NORIDIAN-HEALTHCARE-SOLUTIONS-LLC 80% The MAC responsible for administering claims for laboratory services located in Arizona is Noridian Healthcare Solutions, LLC ("Noridian").

Castle Biosciences, Inc. Customers

TickerNameConfidenceEvidence
MEDICARE MEDICARE 90% Our revenue from patients covered by Medicare as a percentage of total revenue, was 47 % for the year ended December 31, 2024.
COMMERCIAL-PAYOR COMMERCIAL-PAYOR 85% Additionally, there was a commercial payor from which 15 % of our revenue from patients was derived for the year ended December 31, 2024.

Castle Biosciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CSTL-DEBT-8892 Warrants outstanding: 403142 90% xbrl warrant detail from xbrl 2020-12-31.
CSTL-DEBT-8893 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
CSTL-DEBT Debt stack $36.7M 90% Market cache reports total debt of $36.7M.

Castle Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Castle Biosciences, Inc..

Castle Biosciences, Inc. Ownership

HolderNameConfidenceEvidence
CSTL-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 190 tracked holders.

Castle Biosciences, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.